The first cases of severe acute respiratory syndrome (SARS) occurred in China in November
2002. The agent causing this illness has been identified as a novel coronavirus, SARS-…

Background The risk of sexual HIV transmission in serodiscordant couples when the HIV-positive
partner has full virologic suppression on combination antiretroviral therapy (cART) is …

The nature of the HIV epidemic in the United States and Canada has changed with a shift
toward rural areas. Socioeconomic factors, geography, cultural context, and evolving …

Background Raltegravir (MK-0518) is an inhibitor of human immunodeficiency virus type 1 (HIV-1)
integrase active against HIV-1 susceptible or resistant to older antiretroviral drugs. …

Background HIV infection rates are increasing among marginalized women in Ontario,
Canada. HIV-related stigma, a principal factor contributing to the global HIV epidemic, interacts …

Progressive loss of T cell functionality is a hallmark of chronic infection with human
immunodeficiency virus 1 (HIV-1). We have identified a novel population of dysfunctional T cells …

Background We evaluated the efficacy of raltegravir and the development of viral resistance
in two identical trials involving patients who were infected with human immunodeficiency …

ContextSevere acute respiratory syndrome (SARS) is a new clinical entity for which no effective
therapeutic strategy has been developed.ObjectiveTo provide preliminary results on the …

Infection of healthcare workers with the severe acute respiratory syndrome–associated
coronavirus (SARS-CoV) is thought to occur primarily by either contact or large respiratory …

Strongyloidiasis is a chronic infection that may result in significant morbidity; however, diagnosis
and management remain problematic. The objective of this study was to 1) evaluate the …